View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, Oct. 10 (HealthDay News) -- There has been a considerable improvement in viral load suppression and a decrease in the rate of AIDS for patients with HIV who had triple-class virological failure (TCVF) with the three original classes of antiretroviral drugs between 2000 and 2009, according to a study published online Oct. 10 in The Lancet Infectious Diseases.
Dominique Costagliola, Ph.D., from Institut National de la Santé et de la Rechere Médicale in Paris, and colleagues investigated the trends in virological and clinical outcomes for 2,476 participants from the Pursuing Later Treatment Option II project who started antiretroviral therapy for HIV from 1998, but had TCVF and at least one viral load measurement from 2000 to 2009. TCVF was defined as failure to at least two nucleoside reverse transcriptase inhibitors, one non-nucleoside reverse transcriptase inhibitor, and one ritonavir-boosted protease inhibitor. Virological suppression and incidence of AIDS or death after TCVF were assessed after multivariable adjustments.
The investigators found that the percentage of patients who had post-TCVF virological response increased from 19.5 percent in 2000 to 57.9 percent in 2009. The incidence of AIDS per 100 person-years decreased significantly from 7.7 between 2000 and 2002 to 2.3 in 2008 and 1.2 in 2009. Mortality per 100 person-years decreased significantly from 4.0 between 2000 and 2002 to 1.9 in 2007 and 1.4 in 2008. However this trend did not remain significant after adjustments.
"[This improvement] was probably mainly driven by availability of newer drugs with better tolerability and ease of use and small cross-resistance profiles," the authors write.
Several authors disclosed financial relationships with the pharmaceutical industry.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top